1 ence 1.03 [0.79-1.33], p for trend=0.46; for
lifetime prevalence 0.99 [0.83-1.23], p for trend=0.93).
2 Lifetime prevalence (
2.30 [1.50-3.52]) and one-year prev
3 ), but cigar use was also substantial (37.1%
lifetime prevalence,
23.0% past-year prevalence, and 8.5
4 s (50.8%) only slightly higher than observed
lifetime prevalence (
46.4%).
5 Lack of data on the
lifetime prevalence and age at onset of suicide ideation
6 We herein present
lifetime prevalence and comorbidity rates of Axis I diso
7 We seek to estimate
lifetime prevalence and demographic correlates of nonaff
8 The authors found a substantially higher
lifetime prevalence and incidence of anorexia nervosa th
9 We sought to estimate the
lifetime prevalence and overall characteristics of anaph
10 We estimated
lifetime prevalence and point prevalence of vaginal fist
11 The
lifetime prevalence and probandwise concordance rates fo
12 The authors evaluated
lifetime prevalence and specificity of DSM-IV psychiatri
13 the most common of psychiatric diseases (28%
lifetime prevalence)
and contribute to the aetiology of
14 establish whether they described current or
lifetime prevalence,
and those with discrepancies in the
15 The
lifetime prevalence (
approximately 16%) and the economi
16 Increasing
lifetime prevalences are found in recent cohorts.
17 Lifetime prevalence by meta-analysis was shown to be 24.
18 sented nationally representative data on the
lifetime prevalence,
correlates, and comorbidity of shop
19 lt and to illustrate one way of dealing with
lifetime prevalence data.
20 Lifetime prevalence estimates are 22.7% for isolated pan
21 Lifetime prevalence estimates are as follows: anxiety di
22 Country-specific
lifetime prevalence estimates are consistently (median;
23 Lifetime prevalence estimates are higher in recent cohor
24 The respective
lifetime prevalence estimates ascertained by retrospecti
25 Lifetime prevalence estimates of anorexia nervosa, bulim
26 Lifetime prevalence estimates of childhood and adult sep
27 rthermore, no previous studies have compared
lifetime prevalence estimates of common physical disorde
28 In contrast, retrospective
lifetime prevalence estimates of physical disorders asce
29 Lifetime prevalence estimates of psychosis in community
30 The
lifetime prevalence estimates of suicidal ideation, suic
31 Among 4 ethnic-sex groups, the 7.5%
lifetime prevalence for attempts among Caribbean black m
32 Lifetime prevalences for depressive, anxiety, and substa
33 on and severe illnesses which have estimated
lifetime prevalences in the region of 0.8% for bipolar a
34 Lifetime prevalences,
incidence rates, and 5-year recove
35 will appear to be nonrandom comorbidity when
lifetime prevalence is used with mixed-age samples.
36 Neither
lifetime prevalence nor age at onset were related to ADR
37 hypersensitivity reaction with an estimated
lifetime prevalence of 0.5-2.0%.
38 associated with significant impairment and a
lifetime prevalence of 1% to 3%; however, it is often mi
39 Americans and Caribbean Americans, reported
lifetime prevalence of 11.7% for suicide ideation and 4.
40 Overall
lifetime prevalence of AI-SUPERPFP DSM-IV disorders rang
41 scents with firearm access also had a higher
lifetime prevalence of alcohol abuse (10.1% vs 3.8%, P <
42 ffect the population prevalence; the present
lifetime prevalence of all eating disorders is about 5%.
43 stimates for all age groups of self-reported
lifetime prevalence of allergy to cow's milk, egg, wheat
44 The goal of this study was to examine the
lifetime prevalence of antisocial personality disorder a
45 isorder (n=1939) showed no difference in the
lifetime prevalence of anxiety disorders between these s
46 , South America, and Asia, indicate that the
lifetime prevalence of anxiety disorders in individuals
47 In this study, we aimed to quantify the
lifetime prevalence of anxiety disorders in individuals
48 Despite the elevated
lifetime prevalence of anxiety disorders, effective stra
49 bipolar disorder, in which we quantified the
lifetime prevalence of any anxiety disorder in people wi
50 e interval, 1.22-13.40; P =.02) and a higher
lifetime prevalence of any of the syndrome disorders (co
51 The
lifetime prevalence of any psychiatric comorbidity among
52 Lifetime prevalence of any stimulant use was 14.8%, with
53 ory skin disease with early onset and with a
lifetime prevalence of approximately 20%.
54 The
lifetime prevalence of atopic dermatitis was high (34.1%
55 lder than age 4, showed an eightfold greater
lifetime prevalence of attention deficit hyperactivity d
56 In a cross-national survey, the average
lifetime prevalence of binge eating disorder (BED) was 2
57 The US
lifetime prevalence of childhood epilepsy was 1.03% and
58 Lifetime prevalence of comorbid DSM-IV-TR disorders, the
59 Lifetime prevalence of comorbid mental/substance use dis
60 Lifetime prevalence of Composite International Diagnosti
61 This paper describes
lifetime prevalence of consensual male-male sexual behav
62 , no representative epidemiologic studies of
lifetime prevalence of dating violence among adolescents
63 amples, study quality, age of the sample, or
lifetime prevalence of depression.
64 opulation study, we examined the current and
lifetime prevalence of depressive disorders in 4,559 non
65 Twelve-month and
lifetime prevalence of drug abuse and dependence and the
66 The
lifetime prevalence of DSM-5 anorexia nervosa among wome
67 We did a random-effects meta-analysis of
lifetime prevalence of DSM-III and DSM-IV anxiety disord
68 tudies that reported original data about the
lifetime prevalence of DSM-III and DSM-IV anxiety disord
69 The
lifetime prevalence of DSM-IV anorexia nervosa was 2.2%,
70 des, prevalence of anabolic steroid use, and
lifetime prevalence of DSM-IV mood, anxiety, and eating
71 rect relation between both 1-year period and
lifetime prevalence of eczema and water hardness, both b
72 Questionnaire details of 1-year period and
lifetime prevalence of eczema were obtained from parents
73 ed from 30% to 44%, the estimated cumulative
lifetime prevalence of epilepsy using Kaplan-Meier appro
74 nical details were collected, and cumulative
lifetime prevalence of epilepsy was determined using the
75 Lifetime prevalence of exposure to traumatic events and
76 This prospective study suggests that the
lifetime prevalence of GAD and MDD may be underestimated
77 The
lifetime prevalence of having at least 1 suicide attempt
78 This study documents a high
lifetime prevalence of injection drug use in a group of
79 a mean age of 17 years, cases showed a 23.4%
lifetime prevalence of major affective disorders compare
80 n and controlling for age and education, the
lifetime prevalence of major depression in the head inju
81 Estimated
lifetime prevalence of major depression was 20.4% in wom
82 However, the
lifetime prevalence of major depressive disorder, posttr
83 evaluations substantially underestimated the
lifetime prevalence of mental disorders as compared with
84 Lifetime prevalence of mental disorders was 53.2% (95% C
85 n surveys may consistently underestimate the
lifetime prevalence of mental disorders.
86 The
lifetime prevalence of mood disorder in this group was 6
87 s a debilitating psychiatric disorder with a
lifetime prevalence of nearly 8% in the general populati
88 This is the first study of the incidence and
lifetime prevalence of neurological disorders in recent
89 In three of these practices, the
lifetime prevalence of neurological disorders was also a
90 The
lifetime prevalence of neurological disorders was survey
91 Lifetime prevalence of nicotine dependence was 24%, near
92 The
lifetime prevalence of non-war-related sexual assault co
93 The
lifetime prevalence of OCD was significantly higher in c
94 patients with IC had a significantly higher
lifetime prevalence of PD (controlling for age and sex)
95 The
lifetime prevalence of PTSD among these chemically depen
96 The
lifetime prevalence of PTSD was 29.6% (24.3% for males a
97 re an isolated population in Micronesia with
lifetime prevalence of schizophrenia (SCZD) of 2%, compa
98 The
lifetime prevalence of schizophrenia was 2.0%, with a ma
99 Lifetime prevalence of selected mental and physical diso
100 lly distributed questionnaire, to assess the
lifetime prevalence of self-identified depression and su
101 Lifetime prevalence of substance use disorders was 29.1%
102 population survey data are presented on the
lifetime prevalence of suicide attempts as well as trans
103 Several recent studies have found a higher
lifetime prevalence of suicide attempts in homosexual ma
104 The estimate of the
lifetime prevalence of suicide in those ever hospitalize
105 The
lifetime prevalence of traumatic events was 40% and of P
106 The
lifetime prevalence of various provider-diagnosed mental
107 Twelve-month and
lifetime prevalences of AUD were 13.9% and 29.1%, respec
108 Twelve-month and
lifetime prevalences of AUD.
109 By computer algorithm,
lifetime prevalences of narrowly and broadly defined psy
110 Strong associations were found between the
lifetime prevalences of panic and major depressive episo
111 Women exhibit higher
lifetime prevalences of stress-related disorders than me
112 The estimated
lifetime prevalences of suicide ideation, plans, and att
113 Little is known about
lifetime prevalence or age of onset of DSM-IV disorders.
114 To examine changes in the
lifetime prevalence,
patterns, and associated demographi
115 reported to be between 18% and 31%, whereas
lifetime prevalence ranges between 6.7% and 66.7%.
116 Results from studies showed that the
lifetime prevalence rate of bipolar II disorder in adult
117 Lifetime prevalence rates are also reported (expressed a
118 No differences were found in
lifetime prevalence rates between migrant and U.S.-born
119 ican Prevalence and Services Survey presents
lifetime prevalence rates for 12 DSM-III-R psychiatric d
120 Lifetime prevalence rates for all three disorders were h
121 The
lifetime prevalence rates for panic disorder ranged from
122 Lifetime prevalence rates in various countries for bipol
123 Elevated
lifetime prevalence rates of alcohol use disorders (AUDs
124 greater seafood consumption predicted lower
lifetime prevalence rates of bipolar I disorder, bipolar
125 Lifetime prevalence rates of eating disorders, mood diso
126 By clinician diagnosis,
lifetime prevalence rates of narrowly and broadly define
127 Lifetime prevalence rates of physical and sexual dating
128 The absence of a correlation between
lifetime prevalence rates of schizophrenia and seafood c
129 reafter, we recommend that any future use of
lifetime prevalence should require determination of the
130 Lifetime prevalence was 3.0 cases (95% credible interval
131 The corresponding values for
lifetime prevalence were 25.4% (384/1509) and 21.2% (167
132 The aggregate
lifetime prevalences were 0.6% for bipolar type I disord
133 Lifetime prevalences were 31% in women and 24% in men fo
134 f psychiatric comorbidity have been based on
lifetime prevalence with mixed-age samples, a practice t
135 Use of
lifetime prevalence with mixed-age samples, used almost
136 psychiatric diseases, with an estimated 28%
lifetime prevalence worldwide.